Hosted on MSN19m
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue EstimatesMedical device company Integra LifeSciences (NASDAQ:IART) in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million.
Q4 earnings missed the average analyst estimate as operating expenses rose from the prior quarter, exceeding the Wall Street ...
In its core Australian market, we estimate Johns Lyng has high-single-digit share in the insurance repair and restoration construction industry. There are three privately owned competitors with ...
Nvidia’s earnings caps off a Magnificent 7 earnings season that has seen some big tech stocks suffer in the light of DeepSeek ...
Cooper-Standard sees strong free cash flow in Q4 and targets improved EBITDA margins by year-end. Discover growth potential ...
(KTB) on Tuesday reported profit of $64 million in its fourth quarter. The Greensboro, North Carolina-based company said it had ...
With lower unit production costs and profit growth despite lower lithium prices, here’s what we thought of Albemarle’s stock.
Interface Inc. (TILE) on Tuesday reported profit of $21.8 million in its fourth quarter. On a per-share basis, the Atlanta-based company said it had profit of 37 cents.
Comparable sales, a metric also known as same-store sales, increased 0.8% across the company. Those results ended eight ...
Nvidia has led the artificial intelligence boom to become one of the stock market’s biggest companies, as tech giants ...
Booking Holdings delivered better-than-expected results across every operational metric in Q4, including revenues and ...
Okeanis Eco Tankers boasts a modern fleet and distributes nearly all earnings as dividends. Read why I rate ECO stock a Buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results